Latest news

Ulla Grove Krogsgaard Thomsen has decided to step down as CEO of Novo Nordisk Pharmatech

September 8, 2026

Read more

Expansion of distribution partnership in the US

April 22, 2026

Read more

Novo Nordisk Pharmatech Annual Report 2025

March 18, 2026

Read more

Let’s connect at CPhI Worldwide

September 9, 2025

Read more

Celebrating Pride Week

August 11, 2025

Read more

“Skilled people and clear communication”

April 7, 2025

Read more

Vendor show at AstraZeneca

March 28, 2025

Read more

We attend the World Vaccine Congress US

March 24, 2025

Read more

Novo Nordisk Pharmatech Annual Report 2024

March 13, 2025

Read more

Join us at Biologics Manufacturing Asia

February 10, 2025

Read more

Live webinar on March 19, 2025

February 3, 2025

Read more

Expansion of distribution partnership in Europe

January 20, 2025

Read more

Where to meet us in 2025

December 17, 2024

Read more

Novo Nordisk Pharmatech launches TrypsiNNex®

October 29, 2024

Read more

We will attend BPI US 2024

September 20, 2024

Read more

Novo Nordisk Pharmatech is investing 1.5 billion Danish kroner in a new factory in Køge 

August 16, 2024

Read more

New distribution partnership in Europe

June 20, 2024

Read more

We are presenting at World Vaccine Congress

March 14, 2024

Read more

We are attending BPI Europe 2024

March 14, 2024

Read more

Novo Nordisk Pharmatech Annual Report 2023

March 12, 2024

Read more

100 years of Novo Nordisk Insulin

January 1, 2024

Read more

We expand the production

January 1, 2024

Read more

How does Recombinant Insulin differ from animal-derived insulin

January 1, 2024

Read more

Securing your end-to-end supply chain

January 1, 2024

Read more

Safeguarding your regulatory compliance

January 1, 2024

Read more

Take a look inside our cGMP manufacturing facilities

January 1, 2024

Read more

Get peace of mind for your full product life cycle

January 1, 2024

Read more